Drug Research

Argo Biopharmaceutical from China, which happens to be a clinical-stage biotechnology company that’s focused on developing next-generation siRNA therapeutics, has gone on to enter into an additional strategic partnership along with Novartis pertaining to numerous cardiovascular assets that prevail...

The fact remains that the pharmaceutical spectrum happens to stand on the edge of fundamental transformation as the real-world evidence clinical development methods go on to reshape how one gauges the therapeutic intervention. This kind of revolution happens to...

The convergence of genomics, proteomics, transcriptomics, metabolomics, and pathology data represents the most significant advancement in precision medicine since the completion of the Human Genome Project. This multi-omic data integration precision medicine approach promises to revolutionize healthcare by providing...

The fact is that there is something very profoundly poetic about the convergence of quantum physics along with pharmaceutical endeavors. In the sophisticated melody of electrons and molecules, a revolution that is quietly unfolding is the quantum computing advance...

In a significant step toward strengthening India’s efforts in nutrition and metabolism research, Agilent Technologies and the Tata Institute of Fundamental Research (TIFR), Hyderabad have announced a strategic collaboration to support ARUMDA (Advanced Research Unit on Metabolism, Development, and...

In a startling figure, multidrug-resistant bacteria kill almost 5 million people every year, with newly resistant germs emerging faster than the scientists can actually develop the treatments. The researchers have now gone on to develop a platform which can go ahead...

In order to treat multiple myeloma in adults, Sarclisa from Sanofi in combination with a regimen of lenalidomide, bortezomib, and dexamethasone (VRd) has been granted approval by the European Commission. It is well to be noted that Sarclisa has received...